Director Dealing

RNS Number : 5781D
Palace Capital PLC
20 October 2022
 

20 October 2022

 

 

Palace Capital PLC

("Palace Capital", the "Company" or the "Group")

 

Director Dealing

 

Palace Capital announces that Matthew Simpson, Chief Financial Officer, today purchased 8,471 ordinary shares of 10p each at 236.094p per share.

 

For further information, contact:

PALACE CAPITAL PLC

Steven Owen, Interim Executive Chairman / Matthew Simpson, Chief Financial Officer
Tel. +44 (0)20 3301 8330

 

Financial PR 

FTI Consulting

Dido Laurimore/ Giles Barrie

Tel: +44 (0)20 3727 1000

palacecapital@fticonsulting.com

 

About Palace Capital plc ( www.palacecapitalplc.com )

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Matthew Simpson (Chief Financial Officer)

2

Reason for the notification

a)

Position/status

See 1 a) above

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Palace Capital plc

b)

LEI

2138009JDFQOXJFCJQ05

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 Identification code

Ordinary shares of 10 pence each

 

Identification code (ISIN) for Palace Capital plc ordinary shares: GB00BF5SGF06

b)

Nature of the transaction

Acquisition of ordinary shares

c)

Price(s) and volume(s)

 8,471 ordinary shares at 236.094 pence per share

d)

Aggregated information

- Aggregated volume

- Price

 

8,471

236.094p

e)

Date of the transaction

20 October 2022

f)

Place of the transaction

London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFEIIALIFIF
UK 100